Chinua Onyebuchi: Applications Now Open for the European Stroke Master Programme
Chinua Onyebuchi, Specialty Doctor at NHS England, shared on LinkedIn:
”Advancing Stroke Care Through Education: A New Opportunity for Clinicians and Researchers
Stroke remains one of the leading causes of deHematology, Hemostasis, Health, Hemostasis Today, Hemostasis News, Medicine, Thrombosis,
ath and disability worldwide.
Improving outcomes requires more than advances in technology—it requires clinicians and researchers who are equipped with the knowledge, skills, and leadership to translate evidence into practice.
The University of Bern, in partnership with the European Stroke Organisation, has announced applications for the European Stroke Master; a Master of Advanced Studies (MAS) in Stroke Medicine, with registration open from January to August 2027.
This part-time programme (2028–2030) is designed for healthcare professionals working in stroke care and offers comprehensive training across:
- Stroke pathophysiology
- Acute ischaemic and haemorrhagic stroke management
- Primary and secondary prevention
- Neurorehabilitation
- Translational and clinical stroke research
With an international faculty of leading stroke experts, predominantly online delivery, and a three-week on-site component in Switzerland, the programme provides an excellent opportunity to develop advanced expertise while remaining in clinical practice.
As stroke care continues to evolve, investing in postgraduate education is one of the most effective ways to strengthen health systems, improve patient outcomes, and prepare the next generation of stroke specialists.
For clinicians considering a career in stroke medicine, this programme is certainly worth exploring.
Scholarships are also available for eligible applicants.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring